Bristol-Myers Squibb Company (BMY) Earning

NYSE Currency in USD Disclaimer

$57.27

north_east $0.97 (1.72%)
Day's range
$56.08
Day's range
$57.33

Bristol-Myers Squibb Company Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2024 8 -$4.49 -$4.31 -$4.41
Q2 2024 8 $1.62 $1.62 $1.62
Q3 2024 6 $1.45 $1.54 $1.49
Q4 2024 15 $1.41 $1.61 $1.47
Q1 2025 4 $1.68 $1.99 $1.80
Q2 2025 2 $1.84 $1.92 $1.89
Q3 2025 2 $1.82 $1.90 $1.87
Q4 2025 2 $1.65 $1.72 $1.69
Q1 2026 1 $1.57 $1.63 $1.61
Q2 2026 1 $1.81 $1.88 $1.85
Q3 2026 1 $1.96 $2.04 $2.01
Q4 2026 1 $1.69 $1.76 $1.73

Bristol-Myers Squibb Company Earnings Date And Information

Bristol-Myers Squibb Company last posted its earnings results on Thursday, October 31st, 2024. The company reported $1.8 earnings per share for the quarter, topping analysts' consensus estimates of $1.49 by $0.31. The company had revenue of 11.89 B for the quarter and had revenue of 45.01 B for the year. Bristol-Myers Squibb Company has generated $4 earnings per share over the last year ($3.86 diluted earnings per share) and currently has a price-to-earnings ratio of -16.02. Bristol-Myers Squibb Company has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 6th, 2025 based on prior year's report dates.

Bristol-Myers Squibb Company Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
10/31/2024 Q3 2024 $1.49 $0.60 -0.89 $11.26 B $11.89 B
07/26/2024 Q2 2024 $1.62 $0.83 -0.79 $11.54 B $12.20 B
04/25/2024 Q1 2024 -$4.41 -$5.89 -1.48 $11.87 B
02/13/2024 Q4 2023 $0.87 $11.48 B
10/26/2023 Q3 2023 $1.76 $0.94 -0.82 $10.96 B $10.97 B
07/27/2023 Q2 2023 $1.99 $0.99 -1 $11.77 B $11.23 B
04/27/2023 Q1 2023 $1.98 $1.08 -0.9 $11.34 B
02/14/2023 Q4 2022 $0.96 $11.41 B
10/26/2022 Q3 2022 $0.75 $11.14 B $11.22 B
07/27/2022 Q2 2022 $1.79 $0.67 -1.12 $11.42 B $11.89 B
04/29/2022 Q1 2022 $1.92 $0.60 -1.32 $11.65 B
02/09/2022 Q4 2021 $1.10 $11.99 B
10/27/2021 Q3 2021 $1.91 $0.70 -1.21 $11.61 B $11.62 B
07/28/2021 Q2 2021 $1.88 $0.47 -1.41 $11.27 B $11.70 B
04/29/2021 Q1 2021 $1.80 $0.90 -0.9 $11.07 B
02/10/2021 Q4 2020 -$4.45 $11.07 B
11/05/2020 Q3 2020 $1.49 $0.83 -0.66 $10.32 B $10.54 B
08/06/2020 Q2 2020 $1.46 -$0.04 -1.5 $9.99 B $10.13 B
05/07/2020 Q1 2020 $1.48 -$0.34 -1.82 $10.78 B
02/24/2020 Q4 2019 -$0.55 $7.95 B
 

Bristol-Myers Squibb Company Earnings: FAQ's

When is Bristol-Myers Squibb Company's earnings date?

Bristol-Myers Squibb Company has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 6th, 2025 based off last year's report dates.

Did Bristol-Myers Squibb Company beat their earnings estimates last quarter?

In the previous quarter, Bristol-Myers Squibb Company (:BMY) reported $1.8 earnings per share (EPS) to beat the analysts' consensus estimate of $1.49 by $0.31.

How can I listen to Bristol-Myers Squibb Company's earnings conference call?

The conference call for Bristol-Myers Squibb Company's latest earnings report can be listened to online.

How can I read Bristol-Myers Squibb Company's conference call transcript?

The conference call transcript for Bristol-Myers Squibb Company's latest earnings report can be read online.

How much revenue does Bristol-Myers Squibb Company generate each year?

Bristol-Myers Squibb Company (:BMY) has a recorded annual revenue of $45.01 B.

How much profit does Bristol-Myers Squibb Company generate each year?

Bristol-Myers Squibb Company (:BMY) has a recorded net income of $45.01 B. Bristol-Myers Squibb Company has generated $3.88 earnings per share over the last four quarters.

What is Bristol-Myers Squibb Company's price-to-earnings ratio?

Bristol-Myers Squibb Company (:BMY) has a price-to-earnings ratio of -16.02 and price/earnings-to-growth ratio is 1.53.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED